Prediction of disease course in inflammatory bowel diseases
- PMID: 20518078
- PMCID: PMC2880769
- DOI: 10.3748/wjg.v16.i21.2589
Prediction of disease course in inflammatory bowel diseases
Abstract
Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis are heterogeneous and variable over time. Since most patients have a relapsing course and most CD patients develop complications (e.g. stricture and/or perforation), much emphasis has been placed in the recent years on the determination of important predictive factors. The identification of these factors may eventually lead to a more personalized, tailored therapy. In this TOPIC HIGHLIGHT series, we provide an update on the available literature regarding important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors. Our aim is to assist clinicians in the everyday practical decision-making when choosing the treatment strategy for their patients suffering from inflammatory bowel diseases.
Similar articles
-
[Prediction of the disease course in inflammatory bowel diseases].Orv Hetil. 2010 Feb 21;151(8):293-301. doi: 10.1556/OH.2010.28813. Orv Hetil. 2010. PMID: 20154000 Review. Hungarian.
-
Is the disease course predictable in inflammatory bowel diseases?World J Gastroenterol. 2010 Jun 7;16(21):2591-9. doi: 10.3748/wjg.v16.i21.2591. World J Gastroenterol. 2010. PMID: 20518079 Free PMC article.
-
Diagnostic problems and advances in inflammatory bowel disease.Mod Pathol. 2003 Apr;16(4):347-58. doi: 10.1097/01.MP.0000064746.82024.D1. Mod Pathol. 2003. PMID: 12692200 Review.
-
Inflammatory bowel diseases: controversies in the use of diagnostic procedures.Dig Dis. 2009;27(3):269-77. doi: 10.1159/000228560. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786751 Review.
-
Recommendations for identifying Crohn's disease patients with poor prognosis.Expert Rev Clin Immunol. 2013 Jan;9(1):65-75; quiz 76. doi: 10.1586/eci.12.86. Expert Rev Clin Immunol. 2013. PMID: 23256765 Review.
Cited by
-
International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study.BMJ Open. 2020 Jul 1;10(7):e035538. doi: 10.1136/bmjopen-2019-035538. BMJ Open. 2020. PMID: 32611739 Free PMC article.
-
Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare's Milk in the Treatment of Dysbiosis.Biomed Res Int. 2022 Jan 29;2022:3851478. doi: 10.1155/2022/3851478. eCollection 2022. Biomed Res Int. 2022. PMID: 35132375 Free PMC article.
-
Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases.World J Gastroenterol. 2018 Aug 28;24(32):3567-3582. doi: 10.3748/wjg.v24.i32.3567. World J Gastroenterol. 2018. PMID: 30166855 Free PMC article. Review.
-
Current treatment of ulcerative colitis.World J Gastroenterol. 2011 Jul 21;17(27):3204-12. doi: 10.3748/wjg.v17.i27.3204. World J Gastroenterol. 2011. PMID: 21912469 Free PMC article. Review.
References
-
- Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008;103:3082–3093. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources